Amgen/Allergan Target Lucrative Avastin Market With Another Biosimilar Filing

 
• By Ian Schofield
  
European countries
Amgen/Allergan have filed a biosimilar Avastin in Europe
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip